Business Standard

FIIs/FPIs restricted to buy more shares in Fortis, Claris

The FIIs/ FPIs has crossed the overall limit of 24% of its paid-up capital, RBI said

RBI, reserve bank of India
Premium

Press Trust of India Mumbai
The Reserve Bank of India (RBI) said on Wednesday foreign buyers will not be able to buy any more shares in Fortis Healthcare and Claris Lifesciences as the prescribed limit has been reached.

The foreign institutional investors (FIIs)/foreign portfolio investors (FPIs) in Fortis Healthcare Ltd has crossed the overall limit of 24 per cent of its paid-up capital, RBI said.

"Therefore, no further purchases of shares of this company would be allowed through stock exchanges in India on behalf of Foreign institutional Investors (FIIs)/Foreign Portfolio Investors (FPIs)," it added.

In the case of Claris Lifesciences, RBI said holding by FIIs and FPIs too

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in